IL-1α protects intestinal barrier in murine visceral leishmaniasis
mBio · 14.10.2026 · 17 (10)
DOI: 10.1128/mbio.00657-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, erschienen am 14.10.2026. Verfasst von Laís A Sacramento und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil. Hauptthemen laut MEDLINE: Interleukin-1alpha, Leishmaniasis, Visceral, Intestinal Mucosa. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, AOU NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Interleukin-1 (IL-1) is a pleiotropic cytokine important in inflammatory and infectious diseases, but its roles in visceral leishmaniasis (VL) remain poorly understood. Here, we evaluated the role of IL-1 cytokines during experimental visceral leishmaniasis. We showed that IL-1 receptor 1 (IL-1R1) deficiency enhanced the gamma interferon (IFNγ)-mediated response and restricted parasites in an IL-1α-dependent manner, whereas IL-1β deficiency had no effect. The absence of IL-1R1 and IL-1α led to intestinal microbiota dysbiosis. The infection induced IL-1α expression in the gut. The absence of IL-1α led to reduced expression of tight-junction molecules, increased intestinal permeability, and bacterial translocation. These alterations amplified non- Leishmania -specific IFN-γ production, which was reversed by broad-spectrum antibiotic treatment. Bone marrow chimeric transplantation showed that hematopoietic cells are the source of IL-1α during VL. Together, our findings reveal that IL-1α acts as a key regulator of gut barrier integrity in VL and indirectly restrains systemic IFNγ-driven inflammation. This work highlights IL-1α-dependent intestinal protection as an overlooked component of VL pathogenesis. IMPORTANCE Visceral leishmaniasis (VL) is a systemic and chronic disease caused by Leishmania parasites. Most infected individuals remain asymptomatic due to an appropriate IFNγ-mediated response. By contrast, the disease progression is characterized by excessive inflammation, with high levels of cytokines, among them IFNγ. IL-1 cytokines play a role in modulating immune responses and epithelial barriers. We report that IL-1α protects the intestinal environment and indirectly regulates the IFNγ-mediated response during experimental VL. The infection induces IL-1α expression in the intestine, and its absence leads to dysbiosis, gut permeability, and bacterial translocation. Overall, this study reveals the role of IL-1α in intestinal integrity during VL and in regulating the IFNγ-mediated response. Expanding the knowledge of IL-1α in intestinal protection may support therapeutic approaches to improve the outcomes of infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
- Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Academic Institute of Health and Biological Sciences, Goiás State University, Itumbiara, Brazil.
- Fiocruz-Bi-Institutional Translational Medicine Project, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
- Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
ORCID-Profile: Laís A Sacramento, Vanessa Carregaro
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- AOU NIH HHS
- NIAID NIH HHS
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- All of Us Research Program
Zitieren
APA
Sacramento, L. A., Sampaio, P. A., Castilho Martins, G., Benevides, L., Gonzalez-Lombana, C., Trindade, G. B., Mello, M., Cunha, F. Q., Zaramela, L. S., Silva, J. S., Scott, P., & Carregaro, V. (2026). IL-1α protects intestinal barrier in murine visceral leishmaniasis. mBio, 17(10). https://doi.org/10.1128/mbio.00657-26
Vancouver
Sacramento LA, Sampaio PA, Castilho Martins G, Benevides L, Gonzalez-Lombana C, Trindade GB, et al. IL-1α protects intestinal barrier in murine visceral leishmaniasis. mBio. 2026;17(10). doi:10.1128/mbio.00657-26
BibTeX
@article{Sacramento2026,
author = {Sacramento, Laís A and Sampaio, Pedro Alexandre and Castilho Martins, Gabriela and Benevides, Luciana and Gonzalez-Lombana, Claudia and Trindade, Gabrielle B and Mello, Michely and Cunha, Fernando Q and Zaramela, Livia S and Silva, João S and Scott, Phillip and Carregaro, Vanessa},
title = {IL-1α protects intestinal barrier in murine visceral leishmaniasis},
journal = {mBio},
year = {2026},
volume = {17},
number = {10},
doi = {10.1128/mbio.00657-26}
}
EUVIMED